ISEC Healthcare has reported earnings of $4.3 million in 3QFY2024 ended September, up by 11% y-o-y.
This came on the back of the group experiencing a foreign exchange gain of $0.82 million in 3QFY2024 as compared to foreign exchange loss of $0.03 million in 3QFY2023.
Meanwhile, the group’s revenue in 3QFY2024 saw an increase of 5% y-o-y to $0.91 million, due to the increase of revenue contributed by the group’s specialised health services segment following an increase in business activities.
Similarly, gross profit stood at $8.1 million in 3QFY2024, while gross profit margin saw a 1.9% decline to 42.8% in the same period from 44.7% in 3QFY2023. This was mainly due to an increase in business operating costs.
Shares in ISEC Healthcare 40T closed flat at 39 cents on Oct 23.
